Halozyme Therapeutics (HALO) Inventory (2010 - 2026)
Halozyme Therapeutics (HALO) reported Inventory of $137.14 million for Q2 2026, down 24.4% from $181.51 million a year earlier and down 11.8% from the prior quarter.
Halozyme Therapeutics (HALO) Inventory (2010 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics posted Inventory of $176.48 million, up 24.4% from FY2024.
- Inventory has increased for four consecutive years, with a five-year compound annual growth rate of 23.8% (FY2020 to FY2025).
- By year, Inventory came in at $141.86 million in FY2024 (+11.2%), $127.6 million in FY2023 (+27.4%), $100.12 million in FY2022 (+85.7%) and $53.91 million in FY2021 (-11.3%).
- The Q2 2026 figure ranks as the lowest quarterly Inventory since Q3 2024.
- Year over year, Inventory gained in five of the last eight quarters, with growth averaging 7.6%.
- The high point for year-over-year Inventory in five years was Q1 2023 (growth of 125.1%); the low point was Q2 2026 (a decline of 24.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $155.47 million (Q1 2026), $176.48 million (Q4 2025) and $185.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.77 Bn |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 137.14 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 137.14 Mn |
| Mar 31, 2026 | 155.47 Mn |
| Dec 31, 2025 | 176.48 Mn |
| Sep 30, 2025 | 185.80 Mn |
| Jun 30, 2025 | 181.51 Mn |
| Mar 31, 2025 | 164.87 Mn |
| Dec 31, 2024 | 141.86 Mn |
| Sep 30, 2024 | 131.41 Mn |
| Jun 30, 2024 | 159.31 Mn |
| Mar 31, 2024 | 168.54 Mn |
| Dec 31, 2023 | 127.60 Mn |
| Sep 30, 2023 | 128.92 Mn |
| Jun 30, 2023 | 132.41 Mn |
| Mar 31, 2023 | 107.52 Mn |
| Dec 31, 2022 | 100.12 Mn |
| Sep 30, 2022 | 103.28 Mn |
| Jun 30, 2022 | 97.62 Mn |
| Mar 31, 2022 | 47.76 Mn |
| Dec 31, 2021 | 53.91 Mn |
| Sep 30, 2021 | 55.98 Mn |
Halozyme Therapeutics Inventory API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=inventory&ticker=HALO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "inventory", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=inventory&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();